Understanding pals what are common causes of cardiogenic shock is one of the most heavily tested concepts on the PALS written exam. Cardiogenic shock in pediatric patients occurs when the heart fails to pump enough blood to meet the body's metabolic demands, leading to decreased cardiac output and end-organ hypoperfusion. The most common causes include severe cardiomyopathy, myocarditis, congenital heart disease, and dysrhythmias such as supraventricular tachycardia or complete heart block. Recognizing these triggers early is essential because the initial management differs significantly from distributive or hypovolemic shock types.

The PALS written exam tests your ability to differentiate between shock types, identify their underlying causes, and apply the correct treatment algorithms within seconds. Cardiogenic shock is particularly important because its management is counterintuitive — aggressive fluid resuscitation, which helps hypovolemic shock, can actually worsen cardiac output in cardiogenic shock by overwhelming a failing ventricle. Providers must instead focus on reducing afterload, supporting contractility with inotropic agents like dopamine or epinephrine, and treating the primary cardiac dysfunction. This nuanced understanding is precisely what the exam evaluates through scenario-based questions.

Preparing thoroughly for the PALS written exam means mastering more than just shock types. The exam covers airway management, rhythm recognition, resuscitation algorithms, pharmacology, and post-resuscitation care across a wide range of pediatric emergencies. Many candidates find the written portion more challenging than the skills stations because it requires precise recall under time pressure rather than hands-on technique alone. A structured study approach that mirrors the exam's breadth — and reviews actual pals written exam answers — dramatically improves pass rates on the first attempt.

This guide walks through every major content domain you need to master, starting with shock recognition and management, then moving through dysrhythmias, airway emergencies, resuscitation medications, and the post-cardiac arrest care bundle. For each domain, you will find clear explanations of the underlying physiology, concrete exam-style scenarios, and the key decision points that distinguish correct from incorrect answers. Whether you are sitting for initial certification or renewal, the material here reflects the current AHA PALS guidelines and the actual question styles used on the examination.

One of the most important study strategies for any PALS candidate is to use active recall rather than passive reading. Reviewing practice questions forces you to retrieve information under simulated test conditions, which strengthens long-term retention and exposes the specific concepts where your knowledge is weakest. The free quiz tiles embedded throughout this article link to topic-specific practice sets covering cardiac arrest, tachycardia, airway management, and bradycardia — exactly the domains that appear most frequently on the written exam. Plan to cycle through each quiz set at least twice before your exam date.

Time management is another skill that separates candidates who pass comfortably from those who barely scrape through. The PALS written exam typically contains 50 questions with a 90-minute time limit, which allows roughly 90 seconds per question. Questions that present a lengthy clinical scenario followed by a four-choice answer require you to quickly identify the key discriminating detail — often a single vital sign, rhythm finding, or pharmacologic contraindication. Practicing under timed conditions beginning two to three weeks before your exam builds the mental processing speed needed to read carefully and choose accurately without running out of time.

Finally, understanding the exam's scoring structure removes unnecessary anxiety. PALS written exams use a minimum passing score of 84%, meaning you can miss no more than eight questions on a 50-question exam and still pass. This tight margin reinforces why broad, thorough preparation across all content domains is more effective than deep study of just a few topics. Use this guide alongside focused practice quizzes to build comprehensive mastery, and revisit your weakest areas in the final days before your exam.

Cardiogenic shock is defined by inadequate tissue perfusion resulting directly from cardiac pump failure, and understanding its pediatric causes is essential for the PALS written exam. In children, myocarditis — inflammation of the myocardium typically caused by viral infections such as enterovirus, adenovirus, or parvovirus B19 — is among the most common triggers. The inflammation impairs myocyte function, reduces contractility, and can lead to fulminant heart failure within hours to days. Children with myocarditis may present with a history of preceding viral illness followed by rapid deterioration, which is a classic exam scenario.

Cardiomyopathy is another leading cause of cardiogenic shock in pediatric patients. Dilated cardiomyopathy, the most prevalent form, is characterized by ventricular dilation and impaired systolic function. It may be idiopathic, familial, or secondary to chronic tachycardia (tachycardia-induced cardiomyopathy), metabolic disorders, or toxic exposures including anthracycline chemotherapy. On the PALS exam, questions about cardiomyopathy often test your ability to distinguish it from other shock types based on physical exam findings: an enlarged cardiac silhouette on chest X-ray, an S3 gallop, elevated jugular venous pressure, and hepatomegaly all point toward a cardiac etiology rather than volume depletion.

Congenital heart disease (CHD) is a critical cause of cardiogenic shock, particularly in neonates and infants who may present before a structural defect has been diagnosed. Ductal-dependent lesions such as hypoplastic left heart syndrome, critical aortic stenosis, and coarctation of the aorta depend on a patent ductus arteriosus (PDA) to maintain systemic circulation. When the ductus closes in the first days to weeks of life, these infants deteriorate rapidly into cardiogenic shock. Prostaglandin E1 infusion to reopen the ductus is a life-saving intervention that the PALS exam expects providers to recognize and initiate promptly in this clinical scenario.

Dysrhythmias are a reversible cause of cardiogenic shock that every PALS provider must be able to identify and treat. Supraventricular tachycardia (SVT) with rates exceeding 200–220 beats per minute significantly reduces ventricular filling time, causing a dramatic fall in stroke volume and cardiac output. Prolonged SVT can lead to cardiomegaly and ventricular dysfunction that mimics structural cardiomyopathy. Similarly, complete heart block — whether congenital or acquired — reduces heart rate below the minimum needed for adequate output, producing hemodynamic instability that may rapidly progress to cardiac arrest without intervention.

The physical examination findings that differentiate cardiogenic shock from other shock types are high-yield exam material. In cardiogenic shock, the skin is cool and mottled due to compensatory vasoconstriction, pulses are weak and thready, capillary refill is delayed, and work of breathing is increased due to pulmonary edema. Critically, the child in cardiogenic shock often has hepatomegaly and lung crackles — signs of systemic and pulmonary venous congestion — which are absent in pure hypovolemic shock. The presence of these congestive findings is the key discriminator on scenario-based exam questions.

Treatment of pediatric cardiogenic shock is a step-by-step process governed by careful hemodynamic monitoring. The AHA PALS guidelines recommend cautious fluid administration — typically no more than 5–10 mL/kg of isotonic fluid as an initial bolus — to avoid fluid overload in an already compromised heart. Inotropic support with dopamine (5–20 mcg/kg/min) or epinephrine (0.1–1 mcg/kg/min) is initiated to augment contractility and maintain perfusion pressure.

Milrinone, a phosphodiesterase inhibitor with both inotropic and vasodilatory properties, is preferred when systemic vascular resistance is high, as it reduces afterload while supporting output. Vasodilators such as sodium nitroprusside may be added in selected cases under careful monitoring.

For exam purposes, memorize the hemodynamic profile of cardiogenic shock: low cardiac output, high systemic vascular resistance, elevated central venous pressure, and low mixed venous oxygen saturation. This profile contrasts with distributive shock (high output, low SVR), hypovolemic shock (low output, high SVR, low CVP), and obstructive shock (low output, high SVR, high CVP with specific etiologies such as tension pneumothorax or cardiac tamponade). Being able to rapidly classify shock type based on clinical clues and hemodynamic data is the skill that the PALS written exam assesses most rigorously in its shock management section.

PALS pharmacology is a content domain that trips up many candidates because it demands both drug name recognition and precise weight-based dosing calculations under timed conditions. The most frequently tested drugs on the written exam are epinephrine, adenosine, amiodarone, atropine, and glucose. For cardiac arrest, epinephrine is dosed at 0.01 mg/kg (0.1 mL/kg of the 0.1 mg/mL concentration) via IV or IO every 3–5 minutes. This dose applies equally to pulseless VT/VF and to non-shockable arrest rhythms (PEA and asystole), a consistency that simplifies recall but is still tested through scenario variations designed to introduce distraction.

Adenosine is the first-line pharmacologic treatment for stable SVT with a pulse. The initial dose is 0.1 mg/kg (maximum 6 mg) administered as a rapid IV push followed immediately by a normal saline flush to deliver the drug quickly to the heart before it is metabolized. If the first dose fails to convert the rhythm, a second dose of 0.2 mg/kg (maximum 12 mg) is given.

Exam questions about adenosine frequently test the route (IV or IO only, never IM), the rapid-push administration technique, and the need to have a defibrillator immediately available because adenosine briefly interrupts conduction and can rarely trigger ventricular fibrillation as the rhythm converts.

Amiodarone is the preferred antiarrhythmic for shock-refractory VF and pulseless VT. The PALS dose is 5 mg/kg IV/IO as a rapid bolus during cardiac arrest, or administered over 20–60 minutes for stable tachycardia to avoid hypotension. Amiodarone may be repeated twice for a maximum total of three doses (15 mg/kg) in refractory arrest. Lidocaine is an acceptable alternative at 1 mg/kg IV/IO when amiodarone is unavailable. The exam tests your ability to choose between amiodarone and lidocaine based on availability and clinical context, and to recognize that amiodarone requires dilution in D5W for slow infusions outside of cardiac arrest.

Atropine remains important in the PALS bradycardia algorithm, though the emphasis has shifted toward epinephrine infusion for bradycardia caused by increased vagal tone. Atropine is dosed at 0.02 mg/kg IV/IO with a minimum dose of 0.1 mg and a maximum single dose of 0.5 mg in a child. The minimum dose rule exists because doses below 0.1 mg can paradoxically worsen bradycardia through a central vagomimetic effect — a pharmacologic nuance that appears frequently as a distractor or direct question on the written exam. Atropine may be repeated once for a maximum total dose of 1 mg in a child.

Glucose management is a critical pharmacology topic for neonates and infants in particular, since hypoglycemia is both a cause and a complication of pediatric cardiac arrest and shock. The PALS dose for hypoglycemia is dextrose 0.5–1 g/kg IV/IO: this translates to 2 mL/kg of D25W, 5 mL/kg of D10W, or 1 mL/kg of D50W.

The exam tests your ability to choose the appropriate concentration based on the patient's age and vascular access location, since D50W can cause osmotic injury when administered through a peripheral IV in small children, making D10W or D25W preferred options. Always recheck blood glucose after treatment to confirm correction.

Calcium is administered in PALS for documented hypocalcemia, hyperkalemia, hypermagnesemia, or calcium channel blocker toxicity. Calcium chloride (20 mg/kg IV/IO) provides more bioavailable elemental calcium per milliliter than calcium gluconate and is preferred in cardiac arrest scenarios. However, calcium chloride is irritating to veins and should be given through a central line or IO when possible. Outside of the specific indications above, routine calcium supplementation during resuscitation has not been shown to improve outcomes and is not recommended in standard arrest algorithms — a distinction the exam tests to separate evidence-based practice from outdated protocols.

Sodium bicarbonate is another drug with narrow, specific indications in PALS: documented severe metabolic acidosis, hyperkalemia with cardiac toxicity, or tricyclic antidepressant overdose causing sodium channel blockade. Routine bicarbonate use during CPR is not recommended and may actually worsen outcomes by increasing intracellular acidosis, shifting the oxyhemoglobin dissociation curve, and causing hyperosmolarity. The dose is 1 mEq/kg IV/IO given slowly. When the exam presents a pediatric arrest scenario, correct answers regarding bicarbonate hinge on whether a specific indication is stated; if no indication is mentioned, bicarbonate is not the right choice.

Rhythm recognition is a high-stakes skill on the PALS written exam, accounting for 18% of total questions and serving as the foundation for correct algorithm selection in both arrest and peri-arrest scenarios. Tachyarrhythmias are broadly classified as narrow-complex (QRS less than 0.09 seconds) or wide-complex (QRS 0.09 seconds or greater). Narrow-complex tachycardia in a child is almost always SVT — the most common dysrhythmia causing hemodynamic compromise in pediatric patients.

The hallmarks of SVT on a rhythm strip are a ventricular rate typically exceeding 180–220 bpm, a fixed R-R interval with no variability, absent or retrograde P waves, and abrupt onset and termination.

Sinus tachycardia must be distinguished from SVT on the exam, and the differentiating features are clinically important: sinus tachycardia has a rate that varies with clinical status, upright P waves before each QRS, and a rate rarely exceeding 180 bpm in older children. In infants, sinus tachycardia can reach 220 bpm with fever or dehydration, making the distinction more challenging and relying heavily on history and P-wave morphology. A key exam principle is that sinus tachycardia has a treatable underlying cause (fever, pain, hypovolemia, hypoxia), while SVT typically requires direct rhythm management with vagal maneuvers, adenosine, or synchronized cardioversion.

Ventricular tachycardia (VT) in pediatric patients is less common than SVT but immediately life-threatening. Wide-complex tachycardia (WCT) should be treated as VT until proven otherwise, even if the child appears relatively stable. The AHA recommends that stable WCT be treated with amiodarone (5 mg/kg IV over 20–60 minutes) or procainamide, while unstable WCT (hypotension, altered consciousness, signs of shock) requires immediate synchronized cardioversion at 0.5–1 J/kg. Pulseless VT is treated identically to ventricular fibrillation with immediate defibrillation at 2 J/kg followed by CPR and epinephrine — this equivalence is a fundamental exam point.

Bradycardia requiring intervention in PALS is defined as a heart rate less than 60 bpm with signs of poor perfusion: altered mental status, hypotension, respiratory distress, or evidence of shock. The first step is always high-quality CPR if the child is pulseless or has a heart rate below 60 with poor perfusion despite oxygenation and ventilation support.

Vagally mediated bradycardia — such as that caused by laryngoscopy, suctioning, or hypoxia — responds to atropine and correction of the precipitating cause. Primary cardiac causes of bradycardia (complete AV block, sick sinus syndrome) may require emergency transcutaneous pacing when medications fail to restore adequate rate and perfusion.

Complete heart block on a rhythm strip shows independent atrial and ventricular activity: P waves march out at their own rate, QRS complexes appear at a slower independent rate, and there is no consistent PR interval relationship. Congenital complete heart block may be associated with maternal anti-Ro/anti-La antibodies in neonates, while acquired complete heart block in children can result from Lyme disease, cardiac surgery, or myocarditis.

The exam tests your recognition of this rhythm on a 6-second strip and your ability to choose the appropriate intervention: epinephrine or dopamine infusion as a bridge to emergency pacing if the child is hemodynamically compromised.

Atrial flutter in children produces a characteristic sawtooth baseline with flutter waves at 250–350 per minute and a ventricular rate that is a fraction of this (2:1, 3:1, or 4:1 block). It is most commonly seen in children with structural congenital heart disease who have undergone surgical repair, particularly involving atrial tissue.

On the PALS exam, atrial flutter is managed similarly to SVT for unstable patients: synchronized cardioversion at 0.5–1 J/kg. For stable patients, rate control and rhythm conversion are managed in consultation with pediatric cardiology, as antiarrhythmic selection depends on the underlying cardiac substrate. Recognizing the flutter wave pattern quickly on a rhythm strip is a practical skill the exam reinforces through image-based questions.

Post-ROSC (return of spontaneous circulation) care is the final phase of the cardiac arrest algorithm and one that many candidates under-prepare. After achieving ROSC, priorities include maintaining SpO2 at 94–99% (avoiding hyperoxia, which worsens post-anoxic neurologic injury), keeping PaCO2 in the normal range (35–45 mmHg), treating hypotension with fluids and vasopressors to a target mean arterial pressure appropriate for age, and implementing targeted temperature management (TTM) at 32–36°C for 24–48 hours in comatose patients.

The exam tests your understanding that both hyperthermia and aggressive hypothermia are harmful after ROSC, and that tight hemodynamic management during the post-resuscitation phase substantially improves neurologically intact survival rates.

In the final two to three weeks before your PALS written exam, your study strategy should shift from broad coverage to targeted reinforcement of your weakest areas. Begin by completing a full-length practice exam under timed conditions, then sort every question you missed into the relevant content domain: shock management, rhythm recognition, pharmacology, airway, or post-resuscitation care. The domains with the most missed questions represent your highest-yield study targets, and returning to those sections with focused practice questions — rather than re-reading entire chapters — is the most time-efficient use of your remaining preparation hours.

Creating a personal algorithm reference card is a powerful last-week strategy that reinforces memory through writing and produces a quick-review tool for the morning of the exam. Write out the PALS Systematic Approach, the cardiac arrest algorithm (with energy doses and drug doses), the tachycardia with pulse algorithm (stable vs. unstable decision point), and the bradycardia algorithm from memory. Compare your written version to the official AHA algorithms and identify any steps you omitted or got wrong. Repeat this process until you can reproduce each algorithm accurately without reference — this is the level of fluency the exam expects.

Simulation-based practice with a partner or study group adds an important dimension that solo studying cannot replicate. When you verbalize clinical reasoning aloud — explaining why you choose adenosine over cardioversion for stable SVT, or why you choose a careful fluid bolus rather than aggressive resuscitation for cardiogenic shock — you are forced to articulate the exact decision points that multiple-choice questions test. Partners also catch errors in your reasoning that you might overlook when studying alone, particularly in pharmacology (wrong dose, wrong route, wrong concentration) and in algorithm sequencing (skipping a step or reversing the order of interventions).

On exam day, read every question stem carefully before looking at the answer choices. Many PALS exam questions are deliberately constructed to present a clinical scenario that sounds familiar but contains a subtle modifying detail — a specific rhythm finding, a drug contraindication, or a patient age range — that changes the correct answer.

Common traps include stable vs. unstable tachycardia (changing the management from medication to synchronized cardioversion), pediatric vs. adult drug concentrations (epinephrine 1:10,000 vs. 1:1,000), and hypoglycemia dextrose concentration choices. Training yourself to read for these discriminating details during practice sessions prevents costly errors on the actual exam.

Answer every question, even if you are not confident. On the PALS written exam, there is no penalty for incorrect answers, so leaving any question blank is a wasted opportunity. When you encounter a question you are unsure about, eliminate any answer choices you can confidently rule out, then make your best educated guess from the remaining options before moving on.

Flag the question for review and return to it if time permits at the end of the exam. Statistical analysis of standardized exams consistently shows that first instincts are more often correct than second-guessing, so change an answer only when you recall a specific piece of information that clearly supports a different choice.

Understanding the AHA's evidence grading system helps you prioritize study material by clinical importance. Class I recommendations (evidence or general agreement that treatment is beneficial) represent the exam's core expected knowledge — these are the treatments you must know without hesitation. Class IIa and IIb recommendations are where clinical nuance and provider judgment come into play, and exam questions in this zone typically test whether you recognize that an intervention is acceptable rather than mandatory.

Class III (no benefit or harm) recommendations appear as distractor answer choices designed to test whether you have internalized what NOT to do — routine bicarbonate, high-dose epinephrine, and calcium without a specific indication are the most commonly tested Class III traps.

Arriving well-prepared also means being physically ready on exam day. Sleep deprivation impairs working memory and processing speed — exactly the cognitive functions that timed clinical-scenario questions demand. Plan to sleep at least seven hours the night before, eat a balanced meal before the exam, and arrive early enough to complete registration and settle in before the start time.

Anxiety is normal and manageable when it coexists with genuine preparation; it becomes performance-limiting only when it substitutes for preparation. The investment you have made in studying — scenario practice, pharmacology drills, algorithm review — is your most effective anxiety management tool because it produces the confidence that comes from actual competence.